Tramadol Hydrochloride
Product Images NDC 67046-887

4 FDA label images from Contract Pharmacy Services-pa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 67046-887). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Tram50 (Image (328))

Tram50 (Image (328))
Label for TRAMADOL HYDROCHLORIDE 50 mg tablets, in a package of 30 tablets. The label includes barcodes, storage instructions, and states each tablet contains 50 mg tramadol hydrochloride USP. Packaged by Contract Pharmacy Services-PA, with address in Warrington, PA, and includes the NDC 67046-887-30.*
FDA Label Image

Chemical Structure (Tramadol 01)

Chemical Structure (Tramadol 01)
Chemical structure of tramadol hydrochloride showing its molecular formula with labeled functional groups and bonds including a phenyl ring with a methoxy group, a cyclohexane ring, a hydroxyl group, and a dimethylaminoethyl side chain.*
FDA Label Image

Figure 1 (Tramadol 02)

Figure 1 (Tramadol 02)
A pharmacokinetic concentration-time curve showing plasma levels of Tramadol and its metabolite M1 after single and multiple doses, with concentration (ng/mL) on the y-axis and time (hours) on the x-axis. The graph includes four curves representing Tramadol multiple dose, Tramadol single dose, M1 multiple dose, and M1 single dose.*
FDA Label Image

Figure 2 (Tramadol 03)

Figure 2 (Tramadol 03)
A line graph titled 'Protocol CAPSS-047 Time to Discontinuation Due to Nausea/Vomiting' showing the percent of participants discontinuing treatment over days in a double-blind study. The y-axis measures percent discontinuing up to 50%, and the x-axis measures days up to 25, with data for 10 days to 200 mg/day dosing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.